Evaluation of photon interaction parameters of Anti-HIV drugs

MakaleYayıncıda açık erişimScopus SJRQ2
  • SDG 3 · Sağlık ve Kaliteli Yaşam

Özet

Medical treatment inevitably exposes individuals to radiation, including those taking drugs used to treat and prevent human immunodeficiency virus (HIV). Motivated by this, we investigated the radiation interaction properties of several HIV drugs to determine the interaction parameters, mass attenuation coefficient (MAC), atomic cross section (ACS), electronic cross section (ECS), effective atomic numbers (Zeff), and effective electron density (Neff). We calculated the values using the Phy-X/PSD software in the range of 0.015–15 MeV. Additionally, we calculated the exposure build-up factor (EBF), and energy absorption build-up factor (EABF) values of the drugs up to 40 mean free path (MFP) using the geometric progression (G-P) method. From our findings, we determined that Combivir, with its relatively high heavy element content, had the highest radiation attenuation capacity, whereas the probability of Lopinavir interacting with photons was the lowest compared with the other drugs. The results of the EBF and EABF parameters, including the scattering effects, ordered the drugs opposite to the primary interaction parameters such as MAC, ACS, ECS, and Zeff. These findings can guide the treatment process of HIV-positive patients and inform HIV prevention practices conducted alongside radiotherapy, as the interaction between radiation and a drug may cause deterioration in the drug's structure.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/bayburt/12862Resmi atıflarda kullanılan kalıcı adres
İndeks kayıtları
Kaydın indeks veri tabanlarındaki sayfası (aktarımda alınan kayıt numarasıyla). Erişim, indeksin kendi koşullarına bağlıdır.
Atıflar
Scopus
9
WoS
8
OpenAlex
12
Her kaynağın kendi saydığı toplam atıf; aktarım ve zenginleştirme sırasında alındı.
Tam Kayıt
AlanDeğerDil
dc.contributor.authorAkbaba, Uğur
dc.contributor.authorŞakar, Erdem
dc.contributor.authorAbu Al-Sayyed, Mohammed Ibrahim
dc.contributor.authorAlim, Bünyamin
dc.contributor.authorÖzpolat, Özgür Fırat
dc.date.accessioned2026-10-29T19:10:08.933982147Z
dc.date.available2026-10-29T19:10:08.933982147Z
dc.date.issued2022
dc.description.abstractMedical treatment inevitably exposes individuals to radiation, including those taking drugs used to treat and prevent human immunodeficiency virus (HIV). Motivated by this, we investigated the radiation interaction properties of several HIV drugs to determine the interaction parameters, mass attenuation coefficient (MAC), atomic cross section (ACS), electronic cross section (ECS), effective atomic numbers (Zeff), and effective electron density (Neff). We calculated the values using the Phy-X/PSD software in the range of 0.015–15 MeV. Additionally, we calculated the exposure build-up factor (EBF), and energy absorption build-up factor (EABF) values of the drugs up to 40 mean free path (MFP) using the geometric progression (G-P) method. From our findings, we determined that Combivir, with its relatively high heavy element content, had the highest radiation attenuation capacity, whereas the probability of Lopinavir interacting with photons was the lowest compared with the other drugs. The results of the EBF and EABF parameters, including the scattering effects, ordered the drugs opposite to the primary interaction parameters such as MAC, ACS, ECS, and Zeff. These findings can guide the treatment process of HIV-positive patients and inform HIV prevention practices conducted alongside radiotherapy, as the interaction between radiation and a drug may cause deterioration in the drug's structure.
dc.identifier.articlenumber110441
dc.identifier.doi10.1016/j.radphyschem.2022.110441
dc.identifier.eissn1879-0895
dc.identifier.issn0969-806X
dc.identifier.scopus2-s2.0-85135933318
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/bayburt/12862
dc.identifier.volume201
dc.identifier.wosWOS:000892143600004
dc.language.isoen
dc.publisherElsevier Ltd
dc.relation.ispartofRadiation Physics and Chemistry
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectBuild-up factor
dc.subjectHIV drugs
dc.subjectMass attenuation
dc.subjectPhoton–matter interactions
dc.subjectPhy-X/PSD
dc.subject.classificationChemistry, Physical
dc.subject.classificationNuclear Science & Technology
dc.subject.classificationPhysics, Atomic, Molecular & Chemical
dc.subject.classificationChemistry
dc.subject.classificationPhysics
dc.subject.otherAtoms
dc.subject.otherDeterioration
dc.subject.otherDrug interactions
dc.subject.otherPhotons
dc.subject.otherRadiotherapy
dc.subject.otherViruses
dc.subject.otheranti human immunodeficiency virus agent
dc.subject.otheremtricitabine plus tenofovir disoproxil
dc.subject.otherlamivudine plus zidovudine
dc.subject.otherlopinavir
dc.subject.othernelfinavir
dc.subject.othertenofovir
dc.subject.otherAtomic cross sections
dc.subject.otherBuild-up factor
dc.subject.otherElectronic cross sections
dc.subject.otherHuman immunodeficiency virus
dc.subject.otherHuman immunodeficiency virus drug
dc.subject.otherInteraction parameters
dc.subject.otherMass attenuation
dc.subject.otherMass attenuation coefficients
dc.subject.otherPhoton–matter interaction
dc.subject.otherPhy-X/PSD
dc.subject.otherArticle
dc.subject.otherclinical practice
dc.subject.otherdrug determination
dc.subject.otherenergy absorption
dc.subject.othergeometry
dc.subject.otherhuman
dc.subject.othermathematical model
dc.subject.othernonhuman
dc.subject.otherphoton
dc.subject.otherDiseases
dc.titleEvaluation of photon interaction parameters of Anti-HIV drugs
dc.typeArticle
rdl.citation.openalex12
rdl.citation.scopus9
rdl.citation.wos8
rdl.oa.statusclosed
rdl.oa.statusgreen
rdl.scopus.quartileQ2
rdl.sdgSDG03
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)